<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:aavptbiennial-ojs-tamu.tdl.org:article/203</identifier>
				<datestamp>2024-10-30T19:15:51Z</datestamp>
				<setSpec>aavptbiennial:S4</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Subcellular Mechanisms of Intropic Agents</dc:title>
	<dc:creator xml:lang="en">Gwathmey, Judith K.</dc:creator>
	<dc:creator xml:lang="en">Morgan, James P.</dc:creator>
	<dc:subject xml:lang="en">intracellular calcium concentration</dc:subject>
	<dc:subject xml:lang="en">intropic agent</dc:subject>
	<dc:subject xml:lang="en">action mechanism</dc:subject>
	<dc:description xml:lang="en">It is well known that the calcium ion (Ca⁺⁺) plays a central role in excitation-contraction coupling of the mammalian heart. Most interventions with positive or negative intropic effects on the heart either alter the intracellular calcium concentration, change the responsiveness of the myofilaments to calcium, or both. The most direct way to monitor an intropic agent's effect and determine its mechanism of action is to monitor intracellular Ca⁺⁺ transients and correlate them with mechanical events. Aequorin, a bioluminescent indicator that emits light when it binds to free ionized calcium was used to monitor intracellular Ca⁺⁺ levels. Changes in the amplitude and time course of the calcium transient correlate with known subcellular actions of the agents investigated. This correlation has provided the basis for a functional classification scheme· that can be used to investigate drugs with unknown mechanisms of action.</dc:description>
	<dc:publisher xml:lang="en">AAVPT Biennial Symposia</dc:publisher>
	<dc:date>1986-06-10</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/203</dc:identifier>
	<dc:source xml:lang="en">AAVPT Biennial Symposia; Fifth Biennial Symposium; 166-180</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/203/193</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1986 American Academy of Veterinary Pharmacology and Therapeutics</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
